At the International Conference of Alternatives to Animal Experimentation in Portugal, on 8th May 2015, Dr Philip Low presented – to unanimous support – the ‘Declaration of Lisbon‘:
”While recognizing that animal testing has long been a traditional component of biomedical research, it has become clearly apparent that the returns on investment in animal research are increasingly meager. To the extent that this type of research may continue, it is our recommendation that it be carried out after giving institutional committees, independent expert third party animal ethics committees, funding organizations and relevant regulatory authorities evaluating the proposed research (collectively ‘The Parties’) a more realistic and evidence-based estimate of the likely costs and benefits of the proposed protocols.” – view the declaration in full
Dr Bob Coleman, UK Science Director of Safer Medicines Trust, also spoke at the Conference on ‘Humanising Drug Safety Testing’ – view his presentation
